Concepedia

Amy Mikail

AM

Statistics

Publications

3

Citations

529

H-Index

3

Active since

2002

Affiliations

Cedars-Sinai Medical Center(Current)

Amy Mikail is an author at Cedars-Sinai Medical Center specializing in multiple myeloma, genetic risk assessment, and proteasome-mediated degradation.

Publications per year

2002–2005

3

Publications

3

The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents.

Hans Mark, Hank H. Yang, Kimberly M. Parker et al. · PubMed · 2003 · 418 citations

, , +13

Health disparities and advertising content of women's magazines: a cross-sectional study

Susan C. Duerksen, Amy Mikail, Laura S. Tom et al. · BMC Public Health · 2005 · 75 citations · Full text

, , +9

Identification of polymorphisms of the IκBα gene associated with an increased risk of multiple myeloma

Kimberly M. Parker, Hans Mark, Steven J. Manyak et al. · Cancer Genetics and Cytogenetics · 2002 · 36 citations

, , +12

1–3 of 3